Bruker Reports Increased Revenues in Q1, Sells More Hybrid-FTMS Instruments

Bruker Daltonics of Billerica, Mass., reported revenues of $34.1 million for the first quarter of 2003, up from $25.7 million the year before.

The company recorded a net loss of $1.1 million ($0.02 per diluted share) for the quarter, compared with a net income of $900,000 ($0.02 per diluted share) during the same period last year. This loss is due to approximately $1.9 million in costs related to the company’s expected merger with Bruker AXS.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.